Waylis Therapeutics LLC FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection VAI · Feb 12, 2026
  • No warning letters matched by name
Inspections 1 0 OAI
Recalls 0 0 Class I
Warning letters 0 None on file
510(k) clearances 0 None on file

Waylis Therapeutics LLC has 0 FDA recalls, 1 inspection, 0 510(k) clearances and 0 compliance actions on record. No FDA warning letter addressed to "Waylis Therapeutics LLC" is on file. FDA has published 1 Form 483 for Waylis Therapeutics LLC.

What these totals cover: FDA records filed under the name "Waylis Therapeutics LLC" and its spelling variant "Waylis Therapeutics".

Latest inspection
Feb 12, 2026 · VAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls0Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections1Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions0Nov 2, 2026Newest record Oct 29, 2026Current

Reviewing Waylis Therapeutics LLC as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Waylis Therapeutics LLC yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Waylis Therapeutics LLC Form 483s

1 Form 483 published by FDA.

DateDocumentFEI
Feb 12, 2026 · Document on fda.gov 4833021614574

A Form 483 lists the observations FDA investigators made at the end of an inspection. FDA publishes some Form 483s in its reading room, and each date links to that document. Read the observations with the FDA 483 search.

Recent FDA inspections

1 inspection on Feb 12, 2026.

DateSiteProductClassificationFEI
Feb 12, 2026Rahway, NJDrugsVoluntary Action Indicated (VAI)3021614574
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3021614574Rahway, NJ1Feb 12, 2026

Waylis Therapeutics LLC and the FDA: common questions

Has Waylis Therapeutics LLC received an FDA warning letter?

No FDA warning letter addressed to the name "Waylis Therapeutics LLC" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Waylis Therapeutics LLC received an FDA Form 483?

FDA has published 1 Form 483 for Waylis Therapeutics LLC in its reading room, the most recent dated Feb 12, 2026. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Waylis Therapeutics LLC?

The most recent FDA inspection on file ended Feb 12, 2026 at Rahway, NJ and was classified VAI. FDA has 1 inspection of Waylis Therapeutics LLC on file.

Need more than this page shows? Ask about Waylis Therapeutics LLC in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.